Clinical Trials
Data provided by UCSF Profiles, powered by CTSI
| Clinical Trial | Principal Investigator | Related Conditions |
|---|---|---|
| DFC 004 Biomarkers for Active Diabetic Foot Ulcers Study Id: NCT06104969 Start Date: - End Date: Trial Status: Accepting New Patients |
|
|
| BGC101 (EnEPC) Autologous Cell Therapy From Patient's Own Blood for Treatment of Critical Limb Ischemia (CLI) Study Id: NCT02805023 Start Date: - End Date: Trial Status: Accepting New Patients |
|
|
| PROMISE III: Percutaneous Deep Vein Arterialization for the Treatment of Late-Stage Chronic Limb-Threatening Ischemia Study Id: NCT05313165 Start Date: - End Date: Trial Status: Accepting New Patients |
|
|
| Humacyte's HAV for Femoro-Popliteal Bypass in Patients With PAD Study Id: NCT02887859 Start Date: - End Date: |
|
|
| The DES BTK Vascular Stent System vs PTA in Subjects With Critical Limb Ischemia Study Id: NCT03551496 Start Date: - End Date: Trial Status: In Progress, Not Accepting New Patients |
|
|
| Study of AMG0001 to Improve Ulcer Healing and Perfusion in Subjects With Peripheral Ischemic Ulcers Study Id: NCT04267640 Start Date: - End Date: Trial Status: Accepting New Patients |
|
|
| Monitoring Local Tissue Oxygen Changes Using the Wireless Lumee Oxygen Platform in Correlation to TcPO2 Study Id: NCT04514861 Start Date: - End Date: Trial Status: Accepting New Patients |
|
|
| THE OMEGA-SPM-DOSE and OMEGA-SPM-PAD: Specialized Pro-Resolving Mediators in Patients With Peripheral Artery Disease Study Id: NCT02719665 Start Date: - End Date: |
|
|
| Arterial Imaging of Inflammation and Resolution After Endovascular Surgery Study Id: NCT03590769 Start Date: - End Date: |
|
|
| PREDICT-PVI Understanding Peripheral Restenosis: Genomic and Proteomic Determinants of Vascular Intervention Study Id: NCT02180373 Start Date: - End Date: |
|